Custom Search


Sunday, March 02, 2014

MRI-guided, catheter-based cardiac procedures with ClearTrace(R)

MRI Interventions, Inc. (OTCQB:MRIC) announced today that its novel ClearTrace(R) system for MRI-guided, catheter-based cardiac procedures will be featured in a presentation at the 7(th) Annual Western Atrial Fibrillation (AF) Symposium on Feb. 28-March 1 in Park City, Utah. The Western AF Symposium assembles a distinguished faculty of physicians and researchers from five continents to discuss the disorder, its relationship to heart failure, standards for patient care and technical advancements in the field.
On Friday, Dr. Ravi Ranjan, cardiologist at the University of Utah, will give a talk entitled "The AF Ablation Lesion Detected Using MRI," highlighting the need for real-time assessment of lesions during minimally invasive catheter-based cardiac ablation and the techniques developed to enable intraprocedural visualization using MRI Interventions' ClearTrace system.

The application of MRI's unique imaging capabilities is an emerging trend in assessing, staging and treating patients suffering from atrial fibrillation. MRI Interventions is pleased to have the opportunity to participate in this trend with the development of its ClearTrace system. The ClearTrace system will seek to harness the advanced soft-tissue imaging capabilities of MRI to provide real-time visualization of heart tissue, catheters and ablation lesions throughout all phases of a catheter-based procedure. The presentations and discussions at the Western AF Symposium will further advance the dialogue among researchers and clinicians looking to apply next generation imaging technologies to benefit atrial fibrillation patients.



MRI Nueroarm Video